Uric acid as a potential disease modifier in patients with multiple system atrophy
Identifieur interne : 001267 ( Main/Curation ); précédent : 001266; suivant : 001268Uric acid as a potential disease modifier in patients with multiple system atrophy
Auteurs : Ji E. Lee [Corée du Sud] ; Sook K. Song [Corée du Sud] ; Young H. Sohn [Corée du Sud] ; Phil Hyu Lee [Corée du Sud]Source :
- Movement Disorders [ 0885-3185 ] ; 2011-07.
English descriptors
- KwdEn :
Abstract
Background:: Recent studies have suggested that mitochondrial dysfunction and oxidative stress play a key role in the pathogenesis of multiple system atrophy. Methods:: We evaluated the influence of serum uric acid levels on disease progression in 52 patients with multiple system atrophy using changes in the annualized Unified Multiple System Atrophy Rating Scale scores. Results:: The mean annualized Unified Multiple System Atrophy Rating Scale changes were significantly lower in patients with the highest uric acid quartile compared with those with the lowest quartile (8.4 ± 5.1 vs 20.2 ± 16.0, P = .038). Serum uric acid levels had a significant negative correlation with the annualized Unified Multiple System Atrophy Rating Scale changes (r = −0.40, P = .004). Multiple linear regression analysis showed that only serum uric acid concentration was significantly correlated with the annualized Unified Multiple System Atrophy Rating Scale changes (β = −2.687, P = .011). Conclusions:: These data suggest that serum uric acid may act as a potential disease modifier in multiple system atrophy. © 2011 Movement Disorder Society
Url:
DOI: 10.1002/mds.23556
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001488
Links to Exploration step
ISTEX:9FDA783E1D171D8F0B82711CD9D73384D43B8E33Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Uric acid as a potential disease modifier in patients with multiple system atrophy</title>
<author><name sortKey="Lee, Ji E" sort="Lee, Ji E" uniqKey="Lee J" first="Ji E." last="Lee">Ji E. Lee</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Yonsei University College of Medicine, Seoul, Korea</mods:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Neurology, Yonsei University College of Medicine, Seoul</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Song, Sook K" sort="Song, Sook K" uniqKey="Song S" first="Sook K." last="Song">Sook K. Song</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Jeju University College of Medicine, Jeju, Korea</mods:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Neurology, Jeju University College of Medicine, Jeju</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Sohn, Young H" sort="Sohn, Young H" uniqKey="Sohn Y" first="Young H." last="Sohn">Young H. Sohn</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Yonsei University College of Medicine, Seoul, Korea</mods:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Neurology, Yonsei University College of Medicine, Seoul</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lee, Phil Hyu" sort="Lee, Phil Hyu" uniqKey="Lee P" first="Phil Hyu" last="Lee">Phil Hyu Lee</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Yonsei University College of Medicine, Seoul, Korea</mods:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Neurology, Yonsei University College of Medicine, Seoul</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Severance Biomedical Science Institute, Yonsei University, Seoul, South Korea</mods:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Severance Biomedical Science Institute, Yonsei University, Seoul</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:9FDA783E1D171D8F0B82711CD9D73384D43B8E33</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1002/mds.23556</idno>
<idno type="url">https://api.istex.fr/document/9FDA783E1D171D8F0B82711CD9D73384D43B8E33/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001488</idno>
<idno type="wicri:Area/Main/Curation">001267</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Uric acid as a potential disease modifier in patients with multiple system atrophy</title>
<author><name sortKey="Lee, Ji E" sort="Lee, Ji E" uniqKey="Lee J" first="Ji E." last="Lee">Ji E. Lee</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Yonsei University College of Medicine, Seoul, Korea</mods:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Neurology, Yonsei University College of Medicine, Seoul</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Song, Sook K" sort="Song, Sook K" uniqKey="Song S" first="Sook K." last="Song">Sook K. Song</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Jeju University College of Medicine, Jeju, Korea</mods:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Neurology, Jeju University College of Medicine, Jeju</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Sohn, Young H" sort="Sohn, Young H" uniqKey="Sohn Y" first="Young H." last="Sohn">Young H. Sohn</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Yonsei University College of Medicine, Seoul, Korea</mods:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Neurology, Yonsei University College of Medicine, Seoul</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lee, Phil Hyu" sort="Lee, Phil Hyu" uniqKey="Lee P" first="Phil Hyu" last="Lee">Phil Hyu Lee</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Yonsei University College of Medicine, Seoul, Korea</mods:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Neurology, Yonsei University College of Medicine, Seoul</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Severance Biomedical Science Institute, Yonsei University, Seoul, South Korea</mods:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Severance Biomedical Science Institute, Yonsei University, Seoul</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2011-07">2011-07</date>
<biblScope unit="volume">26</biblScope>
<biblScope unit="issue">8</biblScope>
<biblScope unit="page" from="1533">1533</biblScope>
<biblScope unit="page" to="1536">1536</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">9FDA783E1D171D8F0B82711CD9D73384D43B8E33</idno>
<idno type="DOI">10.1002/mds.23556</idno>
<idno type="ArticleID">MDS23556</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>multiple system atrophy</term>
<term>progression</term>
<term>uric acid</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background:: Recent studies have suggested that mitochondrial dysfunction and oxidative stress play a key role in the pathogenesis of multiple system atrophy. Methods:: We evaluated the influence of serum uric acid levels on disease progression in 52 patients with multiple system atrophy using changes in the annualized Unified Multiple System Atrophy Rating Scale scores. Results:: The mean annualized Unified Multiple System Atrophy Rating Scale changes were significantly lower in patients with the highest uric acid quartile compared with those with the lowest quartile (8.4 ± 5.1 vs 20.2 ± 16.0, P = .038). Serum uric acid levels had a significant negative correlation with the annualized Unified Multiple System Atrophy Rating Scale changes (r = −0.40, P = .004). Multiple linear regression analysis showed that only serum uric acid concentration was significantly correlated with the annualized Unified Multiple System Atrophy Rating Scale changes (β = −2.687, P = .011). Conclusions:: These data suggest that serum uric acid may act as a potential disease modifier in multiple system atrophy. © 2011 Movement Disorder Society</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001267 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001267 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonV1 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:9FDA783E1D171D8F0B82711CD9D73384D43B8E33 |texte= Uric acid as a potential disease modifier in patients with multiple system atrophy }}
This area was generated with Dilib version V0.6.23. |